THERAPEUTIC APPLICATIONS OF Spirulina AGAINST HUMAN PATHOGENIC VIRUSES

Authors

  • Sharolynne Xiao Tong Liang Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, 31900 Malaysia
  • Ling Shing Wong Life Science Division, Faculty of Health and Life Sciences, INTI International University, Nilai, 71800 Malaysia
  • Anto Cordelia Tanislaus Antony Dhanapal Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, 31900 Malaysia
  • Prakash Balu Department of Biotechnology, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, 600117, India
  • Sinouvassane Djearamane Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, 31900 Malaysia

DOI:

https://doi.org/10.18006/2021.9(Spl-1-GCSGD_2020).S38.S42

Keywords:

Spirulina, Cyanobacteria, Antiviral, Immunostimulant

Abstract

Viruses can spread worldwide and the early detection of emerging infectious diseases and outbreaks in humans and animals is important for effective surveillance and prevention. Viruses such as human immunodeficiency virus (HIV), swine flu, and influenza virus are some of the viruses that spread diseases worldwide. However, the non-availability of effective antiviral drugs and the drug-resistance among the virus and host have become the major problems in controlling viral infections. The natural products from microalgae can be an alternative therapeutic agent to control viral infections in humans. Spirulina is a well-known cyanobacterium that has been consumed by humans as a food supplement for more than centuries without side-effects. Spirulina possesses high nutritional values and provides numerous health benefits to the consumers. Spirulina can be an alternative natural therapeutic agent for numerous virus infections as it contains several bioactive compounds with proven antiviral effect on enveloped viruses (Herpes simplex virus, measles virus, mumps virus) and non-enveloped viruses (astrovirus, rotavirus) by preventing the spread of the virus in the host cells. Spirulina also serves as a natural supplement that strengthens the immune system. This review focuses on the antiviral properties and immunostimulant effects of Spirulina as a potential therapeutic supplement on human health.

References

Abd El-Baky HH, El-Baroty GS (2020) Spirulina maxima L-asparaginase: Immobilization, Antiviral and Antiproliferation Activities. Recent Patents on Biotechnology 14: 154–163.

Ali SK, Saleh AM (2012) Spirulina-An Overview. International Journal of Pharmacy and Pharmaceutical Sciences 4: 9–15.

Ayehunie S, Belay A, Baba TW, Ruprecht RM (1998) Inhibition of HIV-1 Replication by an Aqueous Extract of Spirulina platensis (Arthrospira platensis): Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18: 7–12.

Balzarini J (2007) Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? Antiviral Chemistry and Chemotherapy 18: 1–11.

Banakar V, Alam Q, Rajendra S, Pandit A, Cladious A, Gnanaprakash K (2020) Spirulina, The Boon of Nature. International Journal of Research in Pharmaceutical Sciences 11: 57–62.

Djearamane S, Lim YM, Wong LS, Lee PF (2018) Cytotoxic effects of zinc oxide nanoparticles on cyanobacterium Spirulina (Arthrospira) platensis. PeerJ 6:e4682

El-Baz FK, El-Senousy WM, El-Sayed AB, Kamel MM (2013.) In vitro antiviral and antimicrobial activities of Spirulina platensis extract. Journal of Applied Pharmaceutical Science 3: 52–56.

Fayyad RJ, Mohammed Ali AN, Dwaish AS, Al-Abboodi AKA (2019) Anticancer Activity of Spirulina platensis Methanolic Extracts Against L20B and MCF7 Human Cancer Cell Lines. Plant Archives 19: 1419–1426.

Hayashi K, Hayashi T, Morita N, Kojima I (1993) An extract from Spirulina platensis is a selective inhibitor of herpes simplex virus type 1 penetration into HeLa cells. Phytotherapy Research 7: 76–80.

Hayashi T (2008) Studies on Evaluation of Natural Products for Antiviral Effects and Their Applications. Yakugaku Zasshi 128: 61–79.

Hernandez-corona A, Nieves I, Meckes M, Chamorro G, Barron B (2002) Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antiviral Research 56: 279–285.

Hoseini SM, Khosravi-Darani K, Mozafari MR (2013) Nutritional and Medical Applications of Spirulina Microalgae. Mini-Reviews in Medical Chemistry 13: 1231–1237.

JosephJ, Karthika T, Ajay A, Das VRA, Raj VS (2020) Green tea and Spirulina extracts inhibit SARS, MERS, and SARS-2 spike pseudotyped virus entry in vitro (preprint). Microbiology.

Jung F, Krüger-Genge A, Waldeck P, Küpper JH (2019) Spirulina platensis, a super food? Journal of Cellular Biotechnology 5: 43–54.

Kameshwari V, Selvaraj S, Sundaramoorthy S (2020) Single Cell Protein Spirulina – A Nutrient Treasure – Review. Research Journal of Pharmacology and Pharmacodynamics 12: 1–7.

Khan Z, Bhadouria P, Bisen P (2005) Nutritional and Therapeutic Potential of Spirulina. Current Pharmaceutical Biotechnology 6: 373–379.

Koonin EV, Senkevich TG, Dolja VV (2006) The ancient Virus World and evolution of cells. Biology Direct 1: 29.

Koyande AK, Chew KW, Rambabu K, Tao Y, Chu DT, Show PL (2019) Microalgae: A potential alternative to health supplementation for humans. Food Science and Human Wellness 8: 16–24.

Martínez-Galero E, Pérez-Pastén R, Perez-Juarez A, Fabila-Castillo L, Gutiérrez-Salmeán G, Chamorro G (2016) Preclinical antitoxic properties of Spirulina (Arthrospira). Pharmaceutical Biology 54: 1345–1353.

Nuhu AA (2013) Spirulina (Arthrospira) : An Important Source of Nutritional and Medicinal Compounds. Journal of Marine Biology 2013: 1–8.

Patterson GML, Baker KK, Baldwin CL, Bolis CM, Caplan FR, Larsen LK, Lavine IA, Moore RE, Nelson CS, Tschappat KD, Tuang GD, Boyd MR, Cardellina JH, Collins RP, Gustafson KR, Snader KM, Weisloi OS, Lewin RA (1993) Antiviral activity of cultured blue-green algae (Cyanophyta)1. Journal of Phycology 29: 125–130.

Rahman MM, Escobedo-Bonilla CM, Wille M, Alday Sanz V, Audoorn L, Neyts J, Pensaert MB, Sorgeloos P, Nauwynck HJ (2006) Clinical effect of cidofovir and a diet supplemented with Spirulina platensis in white spot syndrome virus (WSSV) infected specific pathogen-free Litopenaeus vannamei juveniles. Aquaculture 255: 600–605.

Ramakrishnan R (2013) Antiviral properties of cyanobacterium, Spirulina platensis-A review. International Journal of Medicine and Pharmaceutical Sciences (IJMPS) 3: 1–10.

Reboleira J, Freitas R, Pinteus S, Silva J, Alves C, Pedrosa R, Bernardino S (2019) Spirulina. In Nabavi SM, Silva AS (Ed). Nonvitamin and Nonmineral Nutritional Supplements, Elsevier.

Sharaf M, Amara A, Aboul-Enin A, Helmi S, Astani A, Schnitzler P (2010) Molecular authentication and characterization of the antiherpetic activity of the cyanobacterium Arthrospira fusiformis. Pharmazie 65: 132–136.

Shih SR, Tsai KN, Li YS, Chueh CC, Chan EC (2003) Inhibition of enterovirus 71-induced apoptosis by allophycocyanin isolated from a blue-green alga Spirulina platensis. Journal of Medical Virology 70: 119–125.

Singh S, Dwivedi V, Sanyal D, Dasgupta S (2020) Therapeutic and Nutritional Potential of Spirulina in Combating COVID-19 Infection (preprint).

Teas J, Hebert JR, Fitton JH, Zimba PV (2004) Algae – a poor man’s HAART? Medical Hypotheses 62: 507–510.

Wan D, Wu Q, Kuča K (2016) Spirulina. In: Gupta RC (Ed). Nutraceuticals, Elsevier.

Woolhouse M, Scott F, Hudson Z, Howey R, Chase-Topping M (2012) Human viruses: discovery and emergence. Philosophical Transactions of the Royal Society B: Biological Sciences 367: 2864–2871.

Zainuddin EN, Mentel R, Wray V, Jansen R, Nimtz M, Lalk M, Mundt S (2007) Cyclic Depsipeptides, Ichthyopeptins A and B, from Microcystis ichthyoblabe. Journal of Natural Products 70: 1084–1088.

Downloads

Published

2021-03-25

How to Cite

Liang, S. X. T. ., Wong, L. S. ., Dhanapal, A. C. T. A. ., Balu, P. ., & Djearamane, S. . (2021). THERAPEUTIC APPLICATIONS OF Spirulina AGAINST HUMAN PATHOGENIC VIRUSES. Journal of Experimental Biology and Agricultural Sciences, 9(Spl-1-GCSGD_2020), S38-S42. https://doi.org/10.18006/2021.9(Spl-1-GCSGD_2020).S38.S42